@article{oai:shiga-med.repo.nii.ac.jp:00000177,
 author = {岡本, 圭生 and 村上, 義孝 and 岡田, 裕作},
 issue = {1},
 journal = {滋賀医科大学雑誌},
 month = {Jun},
 note = {Departmental Bulletin Paper, To examine an efficacy and a safety of a generic bicaltamide, we investigated a clinical data before and after shortterm combined hormonal therapy (CAB therapy) using a generic bicaltamide and LH-RH analogue in 66 localized prostatecancer patients treated in Shiga University of Medical Science between 2011 and 2012. We evaluated serum level of PSA,testosterone, LH, FSH before and three months after initiation of CAB therapy. Similarly, we evaluated prostate volume andInternational Prostate Symptom Score (IPSS). Through CAB therapy, serum level of PSA, testosterone, LH, FSH and IPSSwere significantly decreased through CAB therapy. We observed several minor side effects: hot flash (3 cases), breast pain (1case) and itching (1 case). We did not observe any severe side effect. There was no obvious disadvantage by using a genericbicaltamide for CAB therapy. However, long term data should be collected to see the efficacy and the safety of a genericbicaltamide.},
 pages = {49--52},
 title = {非転移性前立腺癌に対するジェネリックビカルタミドとLH-RHアナログ製剤をもちいたCAB療法の短期的効果},
 volume = {27},
 year = {2014}
}